Sinopharma SRL
Sinopharma reported total assets of 70,146 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Aug 2026).
The score of Sinopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -44 % Total assets -12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sinopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 11 Aug 2022
Sinopharma's financial analysis
- Solvency18.2%sector median: 46.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sinopharma
Sinopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0641.889.877
- VAT number
- BE0641889877
- Peppol
- Registered · 0208:0641889877 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Oct 2015
- Registered office
- 7700 Mouscron
- Latest accounts
- 2025 · filed on 05 Aug 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Sinopharma (SRL) has been based in Mouscron since 2015, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 3,218 € and equity of 12,764 €; its revenue is not published. Its solvency stands at 18.2%, below the median of its sector (46.8%).
Companies similar to Sinopharma
Companies in the same business, of comparable size and area, outside its group.
- Axis Benelux Retail sale of medical and orthopaedic goods Tervuren · balance sheet 78,182 €
- Etablissements Goorman Retail sale of medical and orthopaedic goods Charleroi · balance sheet 75,147 €
- Dental SUD Retail sale of medical and orthopaedic goods Namur · balance sheet 34,848 €
- LT&S Corporate Retail sale of medical and orthopaedic goods Woluwe-Saint-Lambert · balance sheet 67,549 €
- DentalSolutionsEU Retail sale of medical and orthopaedic goods Kinrooi · balance sheet 79,153 €
- V&D Pedipro Wholesale of perfume and cosmetics Bassenge · balance sheet 71,049 €
- Azaire Phyto Product Retail sale of medical and orthopaedic goods Flobecq · balance sheet 68,750 €
- NZpharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 74,203 €
Frequently asked questions about Sinopharma
What is the revenue of Sinopharma?
Sinopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sinopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0641889877 for Sinopharma, if the company is VAT-registered. Its company number (CBE) is 0641.889.877.
Where is the registered office of Sinopharma?
According to the CBE register, the registered office of Sinopharma is in 7700 Mouscron.
What is the equity of Sinopharma?
At the close of the 2025 financial year, the equity of Sinopharma amounts to 12,764 €, a solvency of 18.2% of total assets.
Who manages Sinopharma?
The register lists 1 active mandates at Sinopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sinopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →